{"cik":"0001785279","ticker":"MGX","name":"Metagenomi Therapeutics, Inc.","sic_code":"2836","sic_description":"Biological Products, (No Diagnostic Substances)","exchange":"Nasdaq","state_of_incorporation":"","fiscal_year_end":"1231","first_filing_date":"2026-04-27","last_filing_date":"2026-09-11","url":"/sec/cik-0001785279","insider_summary":{"total_transactions":9,"unique_insiders":7,"latest_transaction":"2026-09-09"},"recent_filings":[{"accession_number":"0001193125-26-267170","form_type":"4","form_type_family":"insider","doc_date":"2026-06-11","title":"4 — Metagenomi Therapeutics, Inc. — 2026-06-11","url_slug":"/sec/cik-0001785279/4/0001193125-26-267170","edgar_url":"https://www.sec.gov/Archives/edgar/data/1785279/0001193125-26-267170-index.html"},{"accession_number":"0001193125-26-264392","form_type":"8-K","form_type_family":"current","doc_date":"2026-06-10","title":"8-K — Metagenomi Therapeutics, Inc. — 2026-06-10","url_slug":"/sec/cik-0001785279/8-k/0001193125-26-264392","edgar_url":"https://www.sec.gov/Archives/edgar/data/1785279/0001193125-26-264392-index.html"},{"accession_number":"0001193125-26-265335","form_type":"4","form_type_family":"insider","doc_date":"2026-06-10","title":"4 — Metagenomi Therapeutics, Inc. — 2026-06-10","url_slug":"/sec/cik-0001785279/4/0001193125-26-265335","edgar_url":"https://www.sec.gov/Archives/edgar/data/1785279/0001193125-26-265335-index.html"},{"accession_number":"0001193125-26-265332","form_type":"4","form_type_family":"insider","doc_date":"2026-06-10","title":"4 — Metagenomi Therapeutics, Inc. — 2026-06-10","url_slug":"/sec/cik-0001785279/4/0001193125-26-265332","edgar_url":"https://www.sec.gov/Archives/edgar/data/1785279/0001193125-26-265332-index.html"},{"accession_number":"0001193125-26-265326","form_type":"4","form_type_family":"insider","doc_date":"2026-06-10","title":"4 — Metagenomi Therapeutics, Inc. — 2026-06-10","url_slug":"/sec/cik-0001785279/4/0001193125-26-265326","edgar_url":"https://www.sec.gov/Archives/edgar/data/1785279/0001193125-26-265326-index.html"},{"accession_number":"0001193125-26-182339","form_type":"DEFA14A","form_type_family":"proxy","doc_date":"2026-04-27","title":"DEFA14A — Metagenomi Therapeutics, Inc. — 2026-04-27","url_slug":"/sec/cik-0001785279/defa14a/0001193125-26-182339","edgar_url":"https://www.sec.gov/Archives/edgar/data/1785279/0001193125-26-182339-index.html"},{"accession_number":"0001193125-26-182325","form_type":"DEF 14A","form_type_family":"proxy","doc_date":"2026-04-27","title":"DEF 14A — Metagenomi Therapeutics, Inc. — 2026-04-27","url_slug":"/sec/cik-0001785279/def-14a/0001193125-26-182325","edgar_url":"https://www.sec.gov/Archives/edgar/data/1785279/0001193125-26-182325-index.html"},{"accession_number":"0001193125-26-182345","form_type":"ARS","form_type_family":"other","doc_date":"2026-04-27","title":"ARS — Metagenomi Therapeutics, Inc. — 2026-04-27","url_slug":"/sec/cik-0001785279/ars/0001193125-26-182345","edgar_url":"https://www.sec.gov/Archives/edgar/data/1785279/0001193125-26-182345-index.html"}],"related_endpoints":{"profile":"/sec/MGX/profile","timeline":"/sec/MGX/timeline","peers":"/sec/MGX/peers","insider_pulse":"/sec/MGX/insider-pulse","insider_summary":"/sec/MGX/insider-summary","insider_transactions":"/sec/MGX/insider-transactions","form144":"/sec/MGX/form144","holdings_as_filer":"/sec/MGX/holdings","financial_facts":"/sec/MGX/financial-facts","derivatives":"/sec/MGX/derivatives","officers":"/sec/MGX/officers","insider_network":"/sec/MGX/insider-network","risk_flags":"/sec/MGX/risk-flags","filings":"/sec/MGX/filings","cross_topic_dossier":"/api/v1/dossier?ticker=MGX"}}